Your body uses the SERPINE1 gene to make PAI-1, a protein that slows the breakdown of blood clots so bleeding stays under control. If this gene does not work properly, some people may bruise easily or have delayed bleeding after injury, dental work, surgery, or childbirth. Certain variants that raise PAI-1 activity have also been linked to a higher chance of unwanted clotting in some settings. Many variants are harmless, while a few may change how strongly the gene acts.
What is a gene?
A gene is a section of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. In combination, genes shape the body’s development and day to day function, and they can also influence how you react to food, stress, or medications. To go further into this topic, you can find more in the LearnHub.
Overview
SERPINE1Gene function
What if the gene works
The SERPINE1 gene helps control how your body breaks down blood clots. Its protein also supports wound healing by keeping clot breakdown and tissue repair in balance.
Risk
What if the gene does not work
Milder to more severe variants in the SERPINE1 gene can reduce or disrupt a protein that helps control clot breakdown. This is linked to a bleeding tendency, often with delayed bleeding after injury, surgery, or childbirth, and symptoms can range from mild to more noticeable.
Treatment
What does that mean for your treatment
For complete deficiency caused by pathogenic variants in the SERPINE1 gene, treatment choices center on antifibrinolytic medicines such as tranexamic acid or aminocaproic acid, especially around bleeding, surgery, dental work, and childbirth. Fresh frozen plasma can help when temporary replacement is needed or bleeding continues. Care teams also use extra caution with drugs that increase bleeding.
Conditions associated with SERPINE1
Gene function
What if the gene works
Your body needs a careful balance between making clots and clearing them away, and the SERPINE1 gene helps control blood clot breakdown in the body. It makes the PAI-1 protein, which acts like a brake so clots do not dissolve too soon. This also supports wound healing and normal tissue upkeep.
This gene slows plasminogen activators, proteins that trigger fibrinolysis (normal clot breakdown). That control helps keep a new clot in place long enough for early healing to begin.
PAI-1 helps guide how cells move through surrounding tissue during everyday repair. This supports wound healing and helps damaged areas rebuild in a more organized way.
The protein from this gene also affects how cells attach to and let go of nearby support material. That balance helps tissues remodel, meaning older material can be cleared and replaced as needed.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SERPINE1 gene can reduce the amount of plasminogen activator inhibitor 1 (PAI-1, a protein that slows clot breakdown), make it unstable, or stop cells from making a working protein at all. Milder variants may leave some activity, while more severe variants can lead to little or no PAI-1. SERPINE1 gene variants that cause PAI-1 deficiency often have the strongest functional effect, and in some people this is linked to earlier or more noticeable bleeding.
How variants are linked to conditions
SERPINE1 gene variants are most clearly linked to a rare inherited bleeding condition called plasminogen activator inhibitor-1 deficiency. In this condition, usually caused by harmful variants in both copies of the SERPINE1 gene, bleeding may happen after injury, surgery, dental work, or childbirth, and bruising can be more common. Some common variants in the SERPINE1 gene have also been studied for blood clot and heart disease risk, but those links are less consistent and do not by themselves diagnose a condition.
A variant is not necessarily a diagnosis
Genetic variants are a normal part of human biology and are widely seen in the general population. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For rare SERPINE1-related bleeding, risk is mainly shaped by the inherited gene change, especially when both copies of the gene are affected. Bleeding problems are more likely to show up during surgery, dental work, childbirth, or after a major injury, rather than in everyday life.
Inheritance of SERPINE1 variants
SERPINE1-related plasminogen activator inhibitor-1 deficiency is inherited in an autosomal recessive pattern. This means a person usually develops the condition only if they inherit two disease-causing variants in the SERPINE1 gene, one from each parent. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. This explains how variants of the SERPINE1 gene are inherited in families.
What does my SERPINE1 result mean for my family?
For the rare inherited bleeding condition linked to the SERPINE1 gene, close relatives may also carry the family variant. Brothers and sisters may have the same condition or be carriers, and parents are often carriers even if they have no symptoms. This can matter for relatives with unusual bleeding, or before surgery, dental work, or pregnancy.
Genetic information
Genetic testing
How you find out about variants
Variants in the SERPINE1 gene are found with SERPINE1 genetic testing, which usually analyzes DNA from a blood sample or saliva. The lab reads the gene's sequence to look for known or new variants, and results can help clarify a confirmed diagnosis, carrier status, or whether a family variant is present.
When should I consider getting a genetic test?
Genetic testing for the SERPINE1 gene may be worth discussing if someone has repeated unusual bleeding, especially after surgery, dental work, injury, or childbirth, or if a close relative has a confirmed SERPINE1-related bleeding condition. Testing is usually guided by personal and family history together with clotting test results.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies with the condition and the specific type of variant. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for some people and cause more side effects in others. These differences are common and can help explain why medication response is not the same from one person to the next.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the response to medications. It studies links between genes and drugs to help explain why the same treatment can work differently from one person to another. With many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SERPINE1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so questions about side effects, treatment changes, or unusual responses to a medication are best discussed with your doctor or pharmacist.
History
The SERPINE1 gene entered medical research as scientists worked to understand why some people form clots more easily than others and why the body sometimes has trouble clearing them. In recent decades, awareness of this gene’s role has grown as laboratory studies linked it to blood clotting, wound healing, and broader metabolic health. First described in the scientific literature as part of early genetics, it later gained wider attention through families found to carry rare inherited variants affecting bleeding or clotting patterns. Research on an Amish community in the United States also drew notice when a rare SERPINE1 variant was linked to longer life and lower rates of some age related conditions. From these first observations, research expanded steadily. Today, the gene remains part of ongoing work on thrombosis, aging, and cardiovascular health.